Digestive Care, Inc.
Quick facts
Phase 3 pipeline
- PANCRECARB® (pancrelipase) · Gastroenterology
Pancrelipase is a pancreatic enzyme replacement therapy that supplies lipase, protease, and amylase to aid digestion of fats, proteins, and carbohydrates in patients with pancreatic insufficiency.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Digestive Care, Inc.
What is Digestive Care, Inc.'s pipeline?
Digestive Care, Inc. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include PANCRECARB® (pancrelipase).
Related
- Sector hub: All tracked pharma companies